Egon Zehnder
Search
Select region
Close filter

Content related to Health

Biotech during a pandemic: addressing challenges along the pharma value chain

Evolving personal work patterns are demonstrating people’s amazing adaptability in the face of the pandemic: people are becoming much more comfortable and efficient at using virtual meetings, European Biotech leaders reveal to Egon Zehnder in a recent digital gathering.

The ‘New Normal’ for Biopharma

On June 30, Egon Zehnder virtually gathered 15 top HR leaders from across biopharma, including European-based and U.S.-based companies, ranging from big pharma to start-up biotech. It was a lively discussion, with participants curious to learn from one another and generous in sharing their own insights, hopes, and concerns.

European Biotech CEOs Navigate Towards a “New Normal" Pt 2

Highlights from the fourth round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

Coronavirus – Learnings and Takeaways from Small Biotech

Highlights from the second round of digital gatherings with European Biotech CEOs, hosted by Egon Zehnder.

A Generation of Medicines at Risk

Senior Biotech R&D execs brainstorm on saving clinical trials, modifying procedures, and getting people back to work.

The Outlook from Biopharma Commercial Leaders: What to Expect Next

Egon Zehnder's lessons from how the biopharma industry has responded to Covid-19 with focus, collaboration and resilience.

Risk and Opportunity: Healthcare Leaders in Asia Reflect on Post COVID-19 Recovery

Healthcare CEOs in Asia have embraced that duality and in a teleconference organized by Egon Zehnder, they gathered to discuss the fallout from COVID-19.

Pharma’s High-Stakes Leadership in Times of COVID-19

The pharma and healthcare sector faces a serious threat of operational challenges due to COVID-19. Operations leaders gather to discuss how to move forward.

Discussions with European Biotechs—Bringing Purpose in a Time of Crisis

On April 8 and 9 Egon Zehnder virtually convened a number of biotech board directors to discuss some of the challenges being faced by their companies, often on the front line of responding to COVID-19.

Financials, Clinical Trials, Supply Chain: What Health Care CEOs are Focused on Now

On March 28, our global health care practice convened a virtual meeting with 15 CEOs around the world to discuss how to ensure financial strength, secure the supply chain, and the future of clinical trials.

Changing language

Close icon

You are switching to an alternate language version of the Egon Zehnder website. The page you are currently on does not have a translated version. If you continue, you will be taken to the alternate language home page.

Continue to the website

Back to top